- Report
- August 2025
- 435 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Drug Pipelines
- August 2025
- 900 Pages
Global
From €1879EUR$2,145USD£1,631GBP
€2890EUR$3,300USD£2,509GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 368 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 277 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- March 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- February 2025
- 134 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- September 2024
- 257 Pages
Global
From €2146EUR$2,450USD£1,862GBP
- Report
- July 2023
- 355 Pages
Global
From €3153EUR$3,600USD£2,737GBP
- Report
- May 2023
- 314 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- September 2020
- 124 Pages
Europe
From €3022EUR$3,450USD£2,623GBP

The Non Invasive Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the delivery of drugs to the body without the need for invasive procedures. Non Invasive Drug Delivery systems are designed to provide a safe and effective way to deliver drugs to the body, often through the skin or mucous membranes. These systems can be used to deliver a wide range of drugs, including small molecules, peptides, proteins, and vaccines.
Non Invasive Drug Delivery systems can be divided into two main categories: transdermal and transmucosal. Transdermal systems use patches or other devices to deliver drugs through the skin, while transmucosal systems use devices such as nasal sprays or inhalers to deliver drugs through the mucous membranes. Both systems offer advantages over traditional drug delivery methods, such as improved patient compliance and reduced side effects.
Some companies in the Non Invasive Drug Delivery market include 3M, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more